Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
The Journal of Urology
|
December 1, 1994
High energy shock waves induced increase in the local concentration of systemically given TNF-alpha
E B Cornel, E Oosterwijk, J D van de Streek, et al.
Acta Biomaterialia
|
July 2, 2017
Bioinspired coupled helical coils for soft tissue engineering of tubular structures - Improved mechanical behavior of tubular collagen type I templates
H P Janke, J Bohlin, R M L M Lomme, et al.
Cancer Research
|
December 20, 1999
The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes
J L Vissers, I J De Vries, M W Schreurs, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts
M G Steffens, M H Kranenborg, O C Boerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells
G Li, K Passebosc-Faure, C Lambert, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors
J E Surfus, J A Hank, E Oosterwijk, et al.
International Journal of Cancer
|
January 15, 1994
Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts
J van Dijk, H Uemura, A J Beniers, et al.
British Journal of Cancer
|
November 20, 1998
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas
M G Steffens, E Oosterwijk, N E Zegwaart-Hagemeier, et al.
Anticancer Research
|
June 16, 1999
Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250
M G Steffens, J C Oosterwijk-Wakka, N E Zegwaart-Hagemeier, et al.
Plos One
|
May 23, 2017
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
S De Groot, H M Blommestein, W K Redekop, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
The Journal of Urology
|
December 1, 1994
High energy shock waves induced increase in the local concentration of systemically given TNF-alpha
E B Cornel, E Oosterwijk, J D van de Streek, et al.
Acta Biomaterialia
|
July 2, 2017
Bioinspired coupled helical coils for soft tissue engineering of tubular structures - Improved mechanical behavior of tubular collagen type I templates
H P Janke, J Bohlin, R M L M Lomme, et al.
Cancer Research
|
December 20, 1999
The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes
J L Vissers, I J De Vries, M W Schreurs, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts
M G Steffens, M H Kranenborg, O C Boerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells
G Li, K Passebosc-Faure, C Lambert, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors
J E Surfus, J A Hank, E Oosterwijk, et al.
International Journal of Cancer
|
January 15, 1994
Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts
J van Dijk, H Uemura, A J Beniers, et al.
British Journal of Cancer
|
November 20, 1998
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas
M G Steffens, E Oosterwijk, N E Zegwaart-Hagemeier, et al.
Anticancer Research
|
June 16, 1999
Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250
M G Steffens, J C Oosterwijk-Wakka, N E Zegwaart-Hagemeier, et al.
Plos One
|
May 23, 2017
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
S De Groot, H M Blommestein, W K Redekop, et al.
Page
of 8